Search results
Congress evaluate how to lower prescription prices by increasing competition
WJAX via Yahoo News· 4 days agoMedical experts say competition is key. They say big pharma has a limited period to sell a new drug...
Here's Why You Should Retain Walgreens Boots (WBA) For Now
Zacks via Yahoo Finance· 2 days agoAlliances Look Strategic: The significant element of the company’s growth strategy is partially...
House Members Question FDA Officials on Lab-Developed Tests, Missed Deadlines
MedPage Today· 4 days agoWith all the news about drug shortages, there's another type of possible shortage that the public...
Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In...
Benzinga via Yahoo Finance· 1 day agoA Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 2 days ago“We have a certain degree of exclusivity with that facility that will...shortages. Africa Studio –...
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
Barrons.com· 3 days agoA plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing...
How Do You Get a Prescription for Ozempic?
Parade via Yahoo News· 6 days agoIf you are considering taking Ozempic for weight loss, it’s important to know what it is and how it works. The generic form of Ozempic is semaglutide,...
Hims debuts $199 weight-loss shots, takes aim at Lilly's Zepbound - Indianapolis Business Journal
Indianapolis Business Journal· 6 days agoIn just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by making it easy to...
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 6 days agoThis quarterly report represents an earnings surprise of -53.33%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. , which belongs ...
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
Morningstar· 4 days ago(NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug< ...